Shares in Panion & BF Biotech Inc (寶齡富錦), which makes pharmaceuticals, cosmetics and consumer healthcare products, edged up 0.95 percent yesterday, bucking the TAIEX’s 0.29 percent fall, one day after the company gained approval from the Food and Drug Administration to sell its new kidney drug Nephoxil.
The company said in a filing with the Taiwan Stock Exchange on Thursday night that it might start selling Nephoxil in Taiwan in the second half of the year.
The drug, which treats elevated serum phosphate levels from chronic kidney disease, has already earned the firm royalties from partners in Japan, Europe and the US.
Panion & BF’s estimated sales for this year might rise to NT$1.53 billion, jumping 51.13 percent from an estimated revenue of NT$1.02 billion (US$32.39 million) for the whole of last year, First Capital Management Inc (第一金證券投顧) said in a client note yesterday.
The forecast suggests a big improvement in terms of earnings per share from NT$1.14 last year to NT$8.22 this year, based on estimated sales of US$530 million generated in the US market, US$330 million in Europe and US$28 million in Japan, First Capital said.
Japan Tobacco Inc and subsidiary Torii Pharmaceutical Co began sales of Nephoxil in Japan in May last year, after the kidney drug was certified by Japanese authorities in January last year. The Japanese partners earlier said that sales of Nephoxil (sold under the trade name Riona in Japan) would hit ¥1.2 billion (US$10.3 million) a year. Torii has priced Nephoxil at ¥99.8 per 250mg tablet and an average patient needs between 3g and 6g of the treatment each day.
In 2012, Japan had 312,000 patients on dialysis, the second most worldwide, Panion & BF said, adding that about 80 percent of patients have high phosphate levels.
In the US, Panion & BF has authorized Keryx Biopharmaceuticals Inc to market the new drug. The US partner received a new drug license from the US Food and Drug Administration in September last year, with Nephoxil (sold as Auryxia) hitting the US market on Dec. 22 last year, according to the Taiwanese firm.
Panion & BF said the drug is still under review in Europe, and it has entered a joint venture with China-based Shandong Weigao Pharmaceutical Co (山東威高藥業) to provide kidney disease treatments in China aided by Nephoxil. Nephoxil sales might start in China in four years, according to First Capital.
Stephen Garrett, a 27-year-old graduate student, always thought he would study in China, but first the country’s restrictive COVID-19 policies made it nearly impossible and now he has other concerns. The cost is one deterrent, but Garrett is more worried about restrictions on academic freedom and the personal risk of being stranded in China. He is not alone. Only about 700 American students are studying at Chinese universities, down from a peak of nearly 25,000 a decade ago, while there are nearly 300,000 Chinese students at US schools. Some young Americans are discouraged from investing their time in China by what they see
MAJOR DROP: CEO Tim Cook, who is visiting Hanoi, pledged the firm was committed to Vietnam after its smartphone shipments declined 9.6% annually in the first quarter Apple Inc yesterday said it would increase spending on suppliers in Vietnam, a key production hub, as CEO Tim Cook arrived in the country for a two-day visit. The iPhone maker announced the news in a statement on its Web site, but gave no details of how much it would spend or where the money would go. Cook is expected to meet programmers, content creators and students during his visit, online newspaper VnExpress reported. The visit comes as US President Joe Biden’s administration seeks to ramp up Vietnam’s role in the global tech supply chain to reduce the US’ dependence on China. Images on
New apartments in Taiwan’s major cities are getting smaller, while old apartments are increasingly occupied by older people, many of whom live alone, government data showed. The phenomenon has to do with sharpening unaffordable property prices and an aging population, property brokers said. Apartments with one bedroom that are two years old or older have gained a noticeable presence in the nation’s six special municipalities as well as Hsinchu county and city in the past five years, Evertrust Rehouse Co (永慶房產集團) found, citing data from the government’s real-price transaction platform. In Taipei, apartments with one bedroom accounted for 19 percent of deals last
US CONSCULTANT: The US Department of Commerce’s Ursula Burns is a rarely seen US government consultant to be put forward to sit on the board, nominated as an independent director Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s largest contract chipmaker, yesterday nominated 10 candidates for its new board of directors, including Ursula Burns from the US Department of Commerce. It is rare that TSMC has nominated a US government consultant to sit on its board. Burns was nominated as one of seven independent directors. She is vice chair of the department’s Advisory Council on Supply Chain Competitiveness. Burns is to stand for election at TSMC’s annual shareholders’ meeting on June 4 along with the rest of the candidates. TSMC chairman Mark Liu (劉德音) was not on the list after in December last